Home › Burkitt Lymphoma › NCT06785324
Study of Nutrition and Exercise in Adults Hospitalized for Treatment of Acute Lymphoblastic Leukemia (ALL)
Nutrition and Exercise to Optimize Muscle and Adiposity in Adults With ALL: NEOMA ALL Trial
Who can join
Ages 18 to 50 · All sexes
Full eligibility criteria
Inclusion Criteria: * New Diagnosis of Philadelphia Chromosome Negative B-ALL * Receiving intensive pediatric-inspired induction chemotherapy Exclusion Criteria: * BMI ≤18.5 kg/m2 at time of diagnosis * Unable to comply with both the recommended diet and exercise regimen as deemed by the research or treatment team * Pregnant
About the study
This clinical trial aims to assess the effect of nutrition and exercise on muscle and adiposity in adults with Philadelphia Chromosome (Ph) Negative B-ALL undergoing inpatient induction therapy.
Participants will take part in 2 different interventions:
* Nutrition Intervention * Physical Exercise Intervention
All subjects will be provided with a wearable electronic activity monitor (FitBit®) to assist in recording activity levels in minutes of activity.
What is being tested
- Nutrition Intervention (behavioral)
- Exercise intervention (behavioral)
Sponsor: University of Chicago · Participants: 20 · Started: May 12, 2025
Contact the study team
- Clinical Trials Intake · Phone: 1-855-702-8222
Official record on ClinicalTrials.gov — NCT06785324
Locations in the U.S.
| Illinois | University of Chicago Medicine Comprehensive Cancer Center, Chicago |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.